These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 15169696)
1. A randomized, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. Wagner KD; Robb AS; Findling RL; Jin J; Gutierrez MM; Heydorn WE Am J Psychiatry; 2004 Jun; 161(6):1079-83. PubMed ID: 15169696 [TBL] [Abstract][Full Text] [Related]
2. Fixed-dose trial of the single isomer SSRI escitalopram in depressed outpatients. Burke WJ; Gergel I; Bose A J Clin Psychiatry; 2002 Apr; 63(4):331-6. PubMed ID: 12000207 [TBL] [Abstract][Full Text] [Related]
3. Multicenter, placebo-controlled, fixed-dose study of citalopram in moderate-to-severe depression. Feighner JP; Overø K J Clin Psychiatry; 1999 Dec; 60(12):824-30. PubMed ID: 10665628 [TBL] [Abstract][Full Text] [Related]
4. Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. Appelberg BG; Syvälahti EK; Koskinen TE; Mehtonen OP; Muhonen TT; Naukkarinen HH J Clin Psychiatry; 2001 Jun; 62(6):448-52. PubMed ID: 11465522 [TBL] [Abstract][Full Text] [Related]
5. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor. Lenox-Smith AJ; Jiang Q Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525 [TBL] [Abstract][Full Text] [Related]
6. Citalopram plus low-dose pipamperone versus citalopram plus placebo in patients with major depressive disorder: an 8-week, double-blind, randomized study on magnitude and timing of clinical response. Wade AG; Crawford GM; Nemeroff CB; Schatzberg AF; Schlaepfer T; McConnachie A; Haazen L; Buntinx E Psychol Med; 2011 Oct; 41(10):2089-97. PubMed ID: 21349239 [TBL] [Abstract][Full Text] [Related]
7. A double-blind comparison of escitalopram and venlafaxine extended release in the treatment of major depressive disorder. Bielski RJ; Ventura D; Chang CC J Clin Psychiatry; 2004 Sep; 65(9):1190-6. PubMed ID: 15367045 [TBL] [Abstract][Full Text] [Related]
8. Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Roose SP; Sackeim HA; Krishnan KR; Pollock BG; Alexopoulos G; Lavretsky H; Katz IR; Hakkarainen H; Am J Psychiatry; 2004 Nov; 161(11):2050-9. PubMed ID: 15514406 [TBL] [Abstract][Full Text] [Related]
9. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline. Stahl SM Biol Psychiatry; 2000 Nov; 48(9):894-901. PubMed ID: 11074227 [TBL] [Abstract][Full Text] [Related]
10. Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care. Lepola UM; Loft H; Reines EH Int Clin Psychopharmacol; 2003 Jul; 18(4):211-7. PubMed ID: 12817155 [TBL] [Abstract][Full Text] [Related]
11. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl SM; Gergel I; Li D J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946 [TBL] [Abstract][Full Text] [Related]
12. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder. Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540 [TBL] [Abstract][Full Text] [Related]
13. Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study. Nierenberg AA; Greist JH; Mallinckrodt CH; Prakash A; Sambunaris A; Tollefson GD; Wohlreich MM Curr Med Res Opin; 2007 Feb; 23(2):401-16. PubMed ID: 17288694 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression. Wagner KD; Jonas J; Findling RL; Ventura D; Saikali K J Am Acad Child Adolesc Psychiatry; 2006 Mar; 45(3):280-288. PubMed ID: 16540812 [TBL] [Abstract][Full Text] [Related]
15. Citalopram in the treatment of binge-eating disorder: a placebo-controlled trial. McElroy SL; Hudson JI; Malhotra S; Welge JA; Nelson EB; Keck PE J Clin Psychiatry; 2003 Jul; 64(7):807-13. PubMed ID: 12934982 [TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. Landén M; Björling G; Agren H; Fahlén T J Clin Psychiatry; 1998 Dec; 59(12):664-8. PubMed ID: 9921700 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy and tolerability of escitalopram in anxiety disorders: a review]. Pelissolo A Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243 [TBL] [Abstract][Full Text] [Related]
18. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
19. Evidence based review of escitalopram in treating major depressive disorder in primary care. Einarson TR Int Clin Psychopharmacol; 2004 Sep; 19(5):305-10. PubMed ID: 15289704 [TBL] [Abstract][Full Text] [Related]
20. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning. Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]